MFN2 and Alzheimer disease: Mounting evidence has shown downregulated MFN2 in the brain of rodent AD models (Wu et al., 2014; Tyumentsev et al., 2018) and postmortem AD patients (Manczak et al., 2011; Sita et al., 2020).